ROIVANT SCIENCES LTD (ROIV:NASDAQ)
$36.47 0.11 (0.3025%)
Analysed ROIVANT SCIENCES LTD (ROIV:NASDAQ) News Sources
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
06-08-2026
yahoo.com
Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)
06-08-2026
yahoo.com
Roivant Sciences Q1 Earnings Call Highlights
07-08-2026
marketbeat.com
Roivant Sciences Ltd. Q1 2026 Earnings Call Summary
07-08-2026
moby.co
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
23-07-2026
yahoo.com
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years?
07-07-2026
fool.com
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
06-08-2026
yahoo.com
Roivant Sciences Ltd (ROIV) (Q1 2026) Earnings Call Highlights: Strategic Advances and Strong ...
06-08-2026
yahoo.com
Is Roivant Sciences (ROIV) Overvalued On First Quarter Results?
09-08-2026
yahoo.com
Is Roivant Sciences’ (ROIV) Cost Discipline Offsetting Slower Revenue Enough to Refresh Its Story?
09-08-2026
yahoo.com
What is the current price of ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The current price of ROIVANT SCIENCES LTD (ROIV:NASDAQ) is $36.47.
ROIVANT SCIENCES LTD (ROIV:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROIVANT SCIENCES LTD (ROIV:NASDAQ) since the previous trading day is $0.11.
ROIVANT SCIENCES LTD (ROIV:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROIVANT SCIENCES LTD (ROIV:NASDAQ) since the previous trading day is 0.3025%.
What is the most recent average sentiment score for ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The most recent average sentiment score for ROIVANT SCIENCES LTD (ROIV:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The most recent sentiment for ROIVANT SCIENCES LTD (ROIV:NASDAQ) is .
SEC-8K** Filing Available For ROIVANT SCIENCES LTD (ROIV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.